Business Segments — General and administrative expenses
Vertex Pharmaceuticals Business Segments — General and administrative expenses increased by 7.1% to $180.1M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $155.3M to $180.1M. Over 3 years (FY 2022 to FY 2025), Business Segments — General and administrative expenses shows an upward trend with a 11.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
Rising costs relative to revenue may indicate operational bloat, while stability suggests effective cost management.
Detailed definition
Overhead costs associated with corporate functions such as legal, human resources, finance, and executive management. Th...
Peer comparison
Standardized across all industries as 'General and Administrative' (G&A) expenses.
vrtx_segment_pharmaceuticals_general_and_administrative_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $118.95M | $118.95M | $118.95M | $118.95M | $136.05M | $136.05M | $136.05M | $136.05M | $151M | $175.9M | $154.9M | $144M | $155.3M | $160M | $166.8M | $168.2M | $180.1M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.4% | +0.0% | +0.0% | +0.0% | +11.0% | +16.5% | -11.9% | -7.0% | +7.8% | +3.0% | +4.3% | +0.8% | +7.1% |
| YoY Change | — | — | — | — | +14.4% | +14.4% | +14.4% | +14.4% | +11.0% | +29.3% | +13.9% | +5.8% | +2.8% | -9.0% | +7.7% | +16.8% | +16.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's business segments — general and administrative expenses?
- Vertex Pharmaceuticals (VRTX) reported business segments — general and administrative expenses of $180.1M in Q1 2026.
- How has Vertex Pharmaceuticals's business segments — general and administrative expenses changed year-over-year?
- Vertex Pharmaceuticals's business segments — general and administrative expenses increased by 16.0% year-over-year, from $155.3M to $180.1M.
- What is the long-term trend for Vertex Pharmaceuticals's business segments — general and administrative expenses?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's business segments — general and administrative expenses has grown at a 11.0% compound annual growth rate (CAGR), from $475.8M to $650.3M.
- What does business segments — general and administrative expenses mean?
- General administrative costs required to operate the company's corporate functions.